Strs Ohio Sells 200 Shares of National Health Investors, Inc. (NYSE:NHI)

Strs Ohio reduced its position in shares of National Health Investors, Inc. (NYSE:NHI) by 2.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 8,500 shares of the real estate investment trust’s stock after selling 200 shares during the quarter. Strs Ohio’s holdings in National Health Investors were worth $474,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the stock. Van ECK Associates Corp lifted its position in National Health Investors by 4.3% in the third quarter. Van ECK Associates Corp now owns 4,889 shares of the real estate investment trust’s stock worth $251,000 after buying an additional 202 shares during the last quarter. Sound Income Strategies LLC lifted its position in National Health Investors by 33.5% in the fourth quarter. Sound Income Strategies LLC now owns 916 shares of the real estate investment trust’s stock worth $51,000 after buying an additional 230 shares during the last quarter. Atria Wealth Solutions Inc. lifted its position in National Health Investors by 3.4% in the third quarter. Atria Wealth Solutions Inc. now owns 7,841 shares of the real estate investment trust’s stock worth $403,000 after buying an additional 261 shares during the last quarter. State of Alaska Department of Revenue lifted its position in National Health Investors by 1.4% in the third quarter. State of Alaska Department of Revenue now owns 19,817 shares of the real estate investment trust’s stock worth $1,017,000 after buying an additional 268 shares during the last quarter. Finally, Nomura Asset Management Co. Ltd. lifted its position in National Health Investors by 0.9% in the third quarter. Nomura Asset Management Co. Ltd. now owns 47,540 shares of the real estate investment trust’s stock worth $2,442,000 after buying an additional 420 shares during the last quarter. 62.51% of the stock is currently owned by institutional investors.

Insider Buying and Selling at National Health Investors

In related news, Director Charlotte A. Swafford bought 10,000 shares of the business’s stock in a transaction on Tuesday, February 27th. The shares were bought at an average price of $58.69 per share, for a total transaction of $586,900.00. Following the completion of the purchase, the director now directly owns 110,185 shares of the company’s stock, valued at $6,466,757.65. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 7.26% of the stock is owned by insiders.

National Health Investors Stock Performance

Shares of National Health Investors stock opened at $62.89 on Friday. The firm has a market cap of $2.73 billion, a P/E ratio of 20.09 and a beta of 0.95. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.90. National Health Investors, Inc. has a 12 month low of $47.54 and a 12 month high of $63.37. The stock’s fifty day moving average price is $59.75 and its 200-day moving average price is $55.73.

National Health Investors Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 3rd. Stockholders of record on Thursday, March 28th will be paid a dividend of $0.90 per share. The ex-dividend date of this dividend is Wednesday, March 27th. This represents a $3.60 annualized dividend and a dividend yield of 5.72%. National Health Investors’s dividend payout ratio is currently 115.02%.

Analyst Ratings Changes

NHI has been the subject of a number of analyst reports. Wells Fargo & Company upgraded National Health Investors from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $55.00 to $63.00 in a research report on Monday, February 26th. Truist Financial lifted their target price on National Health Investors from $55.00 to $58.00 and gave the stock a “hold” rating in a research report on Thursday, April 4th. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Wedbush lifted their target price on National Health Investors from $64.00 to $66.00 and gave the stock an “outperform” rating in a research report on Monday, March 18th. Finally, BMO Capital Markets upgraded National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 target price for the company in a research report on Tuesday, March 12th. Five analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $60.50.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.